A Single-subject Study to Examine the Effects of Constrained-induced XXXX Therapy on Naming Deficit.

@entity1 @entity64 @entity51 @entity2026 @entity34
@entity2026 is prevalent in @entity1 following @entity64 , which can have a significant impact on the quality of life of the @entity1 with @entity64 . One of the new methods for treatment of @entity1 with @entity2026 is @entity34 ( @entity34 ). The aim of this study was to investigate the efficacy of @entity51 in individuals with chronic @entity2026 . This study had a prospective, single-subject study with A-B-A design. The @entity34 was administered to two @entity1 with chronic @entity2026 . @entity1 were a 57-year-old male and a 45-year-old female and had a @entity64 60 and 36 months ago, respectively. In this study, the naming test was used as the outcome measure. The naming test was administered in three baseline sessions with 1 week interval between tests (phase A). @entity1 received @entity34 for four consecutive weeks (3 days/week). Four measurements were taken during the treatment phase (phase B). In follow-up phase (phase A) two other measurements were performed. Visual analysis consisting of level, regression line, and variability were used to determine the effects of @entity34 on naming. Both @entity1 increased scores on naming test after phase A and B. The mean of the naming score improved from the baseline to the intervention phase in both @entity1 . There was a positive trend in naming scores during the treatment phase compared with the trend in the baseline demonstrated by both @entity1 . The results of this study showed that the @entity34 can be effective in improving the naming deficit in @entity1 with chronic post- @entity64 @entity2026 .
